AI Analysis AI Analysis of MYGN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add MYGN to Watchlist?
Some Reasons Why To Add MYGN:
  • High gross margin of 70.0%
  • Solid financial health (Piotroski 5/9)
  • Trading above its 200-day moving average
PDF

Strong day for Myriad Genetics stock price on Wednesday rising 5.08% to $6.00
(Updated on Jul 01, 2026)

Buy or Hold candidate since Jun 23, 2026 Gain 29.59%

The Myriad Genetics stock price gained 5.08% on the last trading day (Wednesday, 1st Jul 2026), rising from $5.71 to $6.00. During the last trading day the stock fluctuated 4.89% from a day low at $5.73 to a day high of $6.01. The price has risen in 7 of the last 10 days and is up by 41.18% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 136 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $9.76 million.

Given the current short-term trend, the stock is expected to rise 2.14% during the next 3 months and, with a 90% probability hold a price between $3.69 and $6.13 at the end of this 3-month period.

MYGN Signals & Forecast

Mostly positive signals in the chart today. The Myriad Genetics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.53 and $4.43. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 69.01%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Myriad Genetics stock

Myriad Genetics finds support from accumulated volume at $5.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.280 between high and low, or 4.89%. For the last week, the stock has had daily average volatility of 6.44%.

The Myriad Genetics stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $5.79 (-3.42%) (This stock has high daily movements and this gives high risk. The RSI14 is 79 and this increases the risk substantially. There is a buy signal from a pivot bottom found 29 days ago.)

Trading Expectations (MYGN) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Myriad Genetics to open at $5.91, and during the day (based on 14 day Average True Range), to move between $5.84 and $6.16, which gives a possible trading interval of +/-$0.319 (+/-5.46%) up or down from last closing price. If Myriad Genetics takes out the full calculated possible swing range there will be an estimated 5.46% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $5.88, some $0.120 (2.00%) from the current price of $6.00, our system finds the risk reward attractive.

Is Myriad Genetics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Myriad Genetics stock to perform well in the short-term.

Current score: 4.438 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 2, 2026 - $5.91 ( 1.50%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

MYGN Performance

Trading levels for MYGN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.19 3.17%
R2 6.08 1.38%
R1 6.02 0.283%
Price 6.00
S1 5.80 -3.28%
S2 5.74 -4.38%
S3 5.63 -6.17%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 6.00
S1 5.88 -2.00%
S2 4.63 -22.83%
S3 4.54 -24.33%

MYGN Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jul 01, 2009 Jul 01, 2009 Jul 01, 2009 $1.75 6.73%
2 Jun 15, 2009 Jun 15, 2009 Jun 15, 2009 $1.75 4.93%

FAQ

What is the symbol for Myriad Genetics Stock and on which exchange is it traded?
The symbol for Myriad Genetics is MYGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Myriad Genetics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Myriad Genetics stock to perform well in the short-term.

How to buy Myriad Genetics Stock?
Myriad Genetics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Myriad Genetics Stock.

What's the current price of Myriad Genetics Stock?
As of the end of day on the Jul 01, 2026, the price of an Myriad Genetics (MYGN) share was $6.00.

What is the 52-week high and low for Myriad Genetics Stock?
The 52-week high for Myriad Genetics Stock is $8.59 and the 52-week low is $3.53.

What is the market capitalization of Myriad Genetics Stock?
As of the Jul 01, 2026, the market capitalization of Myriad Genetics is 566.689M.

When is the next earnings date for Myriad Genetics?
The upcoming earnings date for Myriad Genetics is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT MYRIAD GENETICS
Myriad Genetics
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
6.93% Jun 29
IIIV
$20.09
9.33% Jun 25
JLL
$299.78
6.19% Jun 24
NMRK
$15.02
3.00% Jun 24
X
XMAX
$8.34
9.71% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE